http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-1814874-C
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0e951d222788364ebce96092277dcf43 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-08 |
filingDate | 1991-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 1993-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b53e8d13af6d4f0e8c79f4656d3193d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6dc2058f3dc778414a5ecb394f0d687f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_69e422f3b723f37dd68f42d40e71d359 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a9b1f9323c85853e003fae3321158e9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e51423bb1addf3a87402e4ff0974b305 |
publicationDate | 1993-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | RU-1814874-C |
titleOfInvention | Method for prognostication of effectiveness of mountain-climatic treatment of patients ill with bronchial asthma |
abstract | Usage: medicine, pulmonologists. The method is carried out by conducting a test with recurring isocapnic hypoxia with a decrease in blood oxygen saturation of up to 80%. The initial volume and time of the inspiratory flow are determined, the cardiac index is calculated in the initial state, and then at 80% SaOz level. The data obtained are substituted into the formula and the forecast index is calculated: IPr: Ypr 38x (ref VT / Ti) 3 - 22.1 (+ 8 where ref VT is the initial volume of the inspiratory flow, l; ref TI is the initial inspiration time, s; ref SI is the initial cardiac index, l / m2; SI is the difference between the SI indicators of the source and at the sample height, l / m2, 38, 22, 1, 8 are the coefficients obtained when solving nonlinear regression equations with two unknowns. +8 and above, the effectiveness of high-altitude therapy is predicted; at minus 1 and below, the inefficiency of the above treatment method; IPR values up to +2 - the prognosis is zero, ie treatment with an alpine climate does not have a positive or negative effect on the course of the disease.The method allows targeted preliminary selection of patients with bronchial asthma for alpine climatotherapy. |
priorityDate | 1991-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 25.